M. Letko, A. Marzi, and V. Munster, Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses, Nat Microbiol, vol.5, pp.562-569, 2020.

C. M. Ferrario, J. Jessup, and M. C. Chappell, Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2, Circulation, vol.111, pp.2605-2610, 2005.

L. Fang, G. Karakiulakis, and M. Roth, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir Med, 2020.

K. Kuba, Y. Imai, and S. Rao, A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury, Nat Med, vol.11, pp.875-879, 2005.

P. Yang, H. Gu, and Z. Zhao, Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury, Sci Rep, vol.4, p.7027, 2015.

H. Gu, Z. Xie, and T. Li, Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus, Sci Rep, vol.6, 2016.

S. Idell, F. Kueppers, and M. Lippmann, Angiotensin converting enzyme in bronchoalveolar lavage in ARDS, Chest, vol.91, pp.52-56, 1987.

J. Jerng, C. Yu, and H. Wang, Polymorphism of the angiotensinconverting enzyme gene affects the outcome of acute respiratory distress syndrome, Crit Care Med, vol.34, pp.1001-1006, 2006.

Y. Ma, X. Tong, and Y. Liu, ACE gene polymorphism is associated with COPD and COPD with pulmonary hypertension: a meta-analysis, Int J Chron Obstruct Pulmon Dis, vol.13, pp.2435-2446, 2018.

Y. Wang, H. Lu, and Y. Chen, The association of angiotensin-converting enzyme gene insertion/deletion polymorphisms with adaptation to high altitude: A meta-analysis, J Renin Angiotensin Aldosterone Syst, vol.17, p.147032031562741, 2016.

R. Santos, W. O. Sampaio, and A. C. Alzamora, The ACE2/Angiotensin

, /MAS axis of the renin-angiotensin system: focus on angiotensin, vol.98, pp.505-553, 2018.

R. M. Wösten-van-asperen, R. Lutter, and P. A. Specht, Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist, J Pathol, vol.225, pp.618-627, 2011.

Y. Imai, K. Kuba, and S. Rao, Angiotensin-converting enzyme 2 protects from severe acute lung failure, Nature, vol.436, pp.112-116, 2005.

B. Treml, N. Neu, and A. Kleinsasser, Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets, Crit Care Med, vol.38, pp.596-601, 2010.

M. Essig,

V. Zambelli, G. Bellani, and R. Borsa, Angiotensin-(1-7) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental acute respiratory distress syndrome, Intensive Care Med Exp, vol.3, p.44, 2015.

C. P. Sodhi, C. Wohlford-lenane, and Y. Yamaguchi, Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration, Am J Physiol Lung Cell Mol Physiol, vol.314, pp.17-31, 2018.

X. Xie, X. Xudong, and J. Chen, Age-and gender-related difference of ACE2 expression in rat lung, Life Sci, vol.78, pp.2166-2171, 2006.

M. Gupte, S. E. Thatcher, and C. M. Boustany-kari, Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 Mice, Arterioscler Thromb Vasc Biol, vol.32, pp.1392-1399, 2012.

R. Shoemaker, F. Yiannikouris, and S. Thatcher, ACE2 deficiency reduces b-cell mass and impairs b-cell proliferation in obese C57BL/6 mice, Am J Physiol Endocrinol Metab, vol.309, pp.621-631, 2015.

Y. Sun, F. Guo, and Z. Zou, Cationic nanoparticles directly bind angiotensinconverting enzyme 2 and induce acute lung injury in mice, Part Fibre Toxicol, vol.12, p.4, 2015.

X. He, B. Han, and M. Mura, Angiotensin-converting enzyme inhibitor captopril prevents oleic acid-induced severe acute lung injury in rats, Shock, vol.28, pp.106-111, 2007.

H. Su, M. Yang, and C. Wan, Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China, Kidney Int, 2020.

C. P. Larsen, T. D. Bourne, and J. D. Wilson, Collapsing glomerulopathy in a patient with coronavirus disease 2019 (COVID-19), Kidney Int Rep, 2020.

H. Jin, L. Chen, and Z. Zhang, Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling, J Transl Med, vol.13, p.255, 2015.

, COVID-19 and ACE2